Induction chemotherapy with the EXTREME regimen in frail patients with locally advanced head and neck squamous cell carcinoma

Valérie Cochin,Erwan de Monès,Laurence Digue,Muriel Garcia-Ramirez,Charles Dupin,Claire Majoufre,Philipe Fernandez,Amaury Daste

Induction chemotherapy with the EXTREME regimen in frail patients with locally advanced head and neck squamous cell carcinoma

2018

Valérie Cochin
Erwan de Monès
Laurence Digue
Muriel Garcia-Ramirez
Charles Dupin
Claire Majoufre
Philipe Fernandez
Amaury Daste

Background Induction chemotherapy (IC) with TPF (docetaxel, cisplatin, 5FU) for locally advanced head and neck squamous cell carcinoma (LAHNSCC) is limited to fit patients.

Keywords:

Immunology
Regimen
Cisplatin
Head and neck squamous-cell carcinoma
Cancer research
Medicine
Induction chemotherapy
Docetaxel
locally advanced
Internal medicine
Pharmacology
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations